Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher R Flowers

Showing results (191-200 of 430) with videos related to

Pageof 43
Sort By:
Cancer|September 6, 2013
Bortezomib-containing induction regimens in transplant-eligible myeloma patients: a meta-analysis of phase 3 randomized clinical trialsAjay K Nooka, Jonathan L Kaufman, Madhusmita Behera, et al.
International Journal of Radiation Oncology, Biology, Physics|February 12, 2015
Total skin electron therapy for cutaneous T-cell lymphoma using a modern dual-field rotational techniqueThatcher R Heumann, Natia Esiashvili, Sareeta Parker, et al.
Cancer|July 31, 2013
Residence proximity to benzene release sites is associated with increased incidence of non-Hodgkin lymphomaCatherine Bulka, Loretta J Nastoupil, William McClellan, et al.
Cancer|May 30, 2020
Genome-defined African ancestry is associated with distinct mutations and worse survival in patients with diffuse large B-cell lymphomaMichelle J Lee, Jean L Koff, Jeffrey M Switchenko, et al.
Leukemia & Lymphoma|December 20, 2019
Biologic, clinical, and sociodemographic predictors of multi-agent systemic therapy for non-Hodgkin lymphoma in people living with HIV: a population-based investigation in the state of GeorgiaJoseph Lipscomb, Jeffrey M Switchenko, Christopher R Flowers, et al.
American Journal of Hematology|April 29, 2016
Disease, treatment, and outcome differences between men and women with follicular lymphoma in the United StatesChadi Nabhan, Xiaolei Zhou, Bann-Mo Day, et al.
Leukemia & Lymphoma|March 9, 2019
Clinical impact of Internet-based tools to guide therapeutic decisions for mantle cell lymphomaSrinivasa N Gopalsamy, Kristen M Rosenthal, Amy A Ayers, et al.
Cancer|January 17, 2020
Clustering of cutaneous T-cell lymphoma is associated with increased levels of the environmental toxins benzene and trichloroethylene in the state of GeorgiaLindsay Clough, A Rana Bayakly, Kevin C Ward, et al.
Blood|September 17, 2010
Tipifarnib sensitizes cells to proteasome inhibition by blocking degradation of bortezomib-induced aggresomesEbenezer David, Jonathan L Kaufman, Christopher R Flowers, et al.
Cancer|March 27, 2014
The use and effectiveness of rituximab maintenance in patients with follicular lymphoma diagnosed between 2004 and 2007 in the United StatesLoretta J Nastoupil, Rajni Sinha, Michelle Byrtek, et al.
Pageof 43

Showing results (191-200 of 430) with videos related to

Sort By:
Pageof 43
Cancer|September 6, 2013
Bortezomib-containing induction regimens in transplant-eligible myeloma patients: a meta-analysis of phase 3 randomized clinical trialsAjay K Nooka, Jonathan L Kaufman, Madhusmita Behera, et al.
International Journal of Radiation Oncology, Biology, Physics|February 12, 2015
Total skin electron therapy for cutaneous T-cell lymphoma using a modern dual-field rotational techniqueThatcher R Heumann, Natia Esiashvili, Sareeta Parker, et al.
Cancer|July 31, 2013
Residence proximity to benzene release sites is associated with increased incidence of non-Hodgkin lymphomaCatherine Bulka, Loretta J Nastoupil, William McClellan, et al.
Cancer|May 30, 2020
Genome-defined African ancestry is associated with distinct mutations and worse survival in patients with diffuse large B-cell lymphomaMichelle J Lee, Jean L Koff, Jeffrey M Switchenko, et al.
Leukemia & Lymphoma|December 20, 2019
Biologic, clinical, and sociodemographic predictors of multi-agent systemic therapy for non-Hodgkin lymphoma in people living with HIV: a population-based investigation in the state of GeorgiaJoseph Lipscomb, Jeffrey M Switchenko, Christopher R Flowers, et al.
American Journal of Hematology|April 29, 2016
Disease, treatment, and outcome differences between men and women with follicular lymphoma in the United StatesChadi Nabhan, Xiaolei Zhou, Bann-Mo Day, et al.
Leukemia & Lymphoma|March 9, 2019
Clinical impact of Internet-based tools to guide therapeutic decisions for mantle cell lymphomaSrinivasa N Gopalsamy, Kristen M Rosenthal, Amy A Ayers, et al.
Cancer|January 17, 2020
Clustering of cutaneous T-cell lymphoma is associated with increased levels of the environmental toxins benzene and trichloroethylene in the state of GeorgiaLindsay Clough, A Rana Bayakly, Kevin C Ward, et al.
Blood|September 17, 2010
Tipifarnib sensitizes cells to proteasome inhibition by blocking degradation of bortezomib-induced aggresomesEbenezer David, Jonathan L Kaufman, Christopher R Flowers, et al.
Cancer|March 27, 2014
The use and effectiveness of rituximab maintenance in patients with follicular lymphoma diagnosed between 2004 and 2007 in the United StatesLoretta J Nastoupil, Rajni Sinha, Michelle Byrtek, et al.
Pageof 43